Clinical Trials
 
There are a number of portfolio clinical studies at the Sheffield Kidney Institute. These are listed are below.
  • CCRN 005 INEOS ACT 402 sth 15219 – Fermagate – (MEW is the CI for the UK).
  • About- K study – NIHR CRN portfolio study id 687 (WSM will be the PI)
  • Dialysis outcomes and practice patterns study 4 – submitted to NIHR portfolio – (MEW PI).
  • NIHR CRN portfolio 10790 – bioelectrical impedance in peritoneal dialysis – (SBJ PI).
  • RituxiCAN-C4 - Randomised controlled trial of anti-CD20 in patients with C4d+ chronic allograft nephropathy – being submitted to the portfolio (WSM as PI).
  • Myfortic in proteinuric glomerulonephritis (GLOMY)
  • UK EPS study and DNA bank (MEW PI and UK logistics lead) – portfolio status pending
  • SHARP study (AMEN = PI); portfolio status
  • UK CRN portfolio id number: 5807 - a multi-centre randomised trial to assess whether increased dietary fibre … in free living PD patients (MEW PI).